Filtros de búsqueda

Lista de obras de Eric Van Cutsem

90Y-edotreotide for metastatic carcinoid refractory to octreotide

artículo científico publicado en 2010

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma

artículo científico publicado en 2008

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen

artículo científico publicado en 2012

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials

artículo científico publicado en 2012

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study ⬇️

artículo científico publicado el 13 de septiembre de 2010

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

artículo científico publicado en 2008

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

artículo científico publicado en 2004

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

artículo científico publicado en 2010

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

artículo científico publicado en 2012

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

artículo científico publicado en 2015

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

artículo científico publicado en 2009

Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer

artículo científico publicado en 2006

Clinical presentation and pathophysiology of EGFRI dermatologic toxicities

artículo científico publicado en 2007

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study

artículo científico publicado en 2008

Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database

artículo científico publicado en 2013

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

artículo científico publicado en 2012

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

artículo científico publicado en 2009

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials

artículo científico publicado en 2010

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

artículo científico publicado en 2005

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

artículo científico publicado en 2007

Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer

artículo científico publicado en 2008

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

artículo científico publicado en 2010

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

artículo científico publicado en 2015

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

artículo científico publicado en 2015

Everolimus for advanced pancreatic neuroendocrine tumors.

artículo científico publicado en 2011

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

artículo científico publicado en 2008

Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial

artículo científico publicado en 2013

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting ⬇️

artículo científico publicado el 24 de enero de 2011

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

artículo científico publicado en 2014

Hepatic radiation injury mimicking metastasis in distal esophageal cancer

artículo científico publicado en 2016

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians

artículo científico publicado en 2016

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database

artículo científico publicado en 2013

Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial

artículo científico publicado en 2015

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report

artículo científico publicado en 2017

Integration of the anti-EGFR agent panitumumab into clinical practice in metastatic colorectal cancer

artículo científico publicado en 2007

Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer

artículo científico publicado en 2005

Leptomeningeal carcinomatosis associated with oesophageal adenocarcinoma: two case reports and review of the literature

artículo científico publicado en 2006

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

artículo científico publicado en 2017

Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda).

artículo científico publicado en 2004

Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus

artículo científico publicado en 2015

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer

artículo científico publicado en 2013

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

artículo científico publicado en 2007

Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review

artículo científico publicado en 2020

Molecular and genetic defects in colorectal tumorigenesis

artículo científico publicado en 2002

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

artículo científico publicado en 2006

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

artículo científico publicado en 2010

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

artículo científico publicado en 2007

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment

artículo científico publicado en 2005

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

scientific article published on 01 December 2020

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

artículo científico publicado en 2013

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

artículo científico publicado en 2008

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

artículo científico publicado en 2018

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer

artículo científico publicado en 2013

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

artículo científico publicado en 2006

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

artículo científico publicado en 2020

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies

artículo científico publicado en 2013

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

artículo científico publicado en 2017

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

artículo científico publicado en 2010

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

artículo científico publicado en 2012

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, doubl

artículo científico publicado en 2015

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer

artículo científico publicado en 2017

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.

artículo científico publicado en 2017

Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer

artículo científico publicado en 2014

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

artículo científico publicado en 2014

Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer

artículo científico publicado en 2014

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.

artículo científico publicado en 2015

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis

artículo científico publicado en 2013

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

artículo científico publicado en 2013

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

artículo científico publicado en 2011

Systemic treatment of pancreatic cancer

artículo científico publicado en 2004

T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the VHgene mutation status ⬇️

artículo científico publicado el 15 de febrero de 2011

The causes and consequences of cancer-associated malnutrition

artículo científico publicado en 2005

The continuum of care: a paradigm for the management of metastatic colorectal cancer

artículo científico publicado en 2007

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

artículo científico publicado en 2005

The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer

scientific article published on January 2007

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus

artículo científico publicado en 2012

The role of chemotherapy in the current treatment of gastric cancer

artículo científico publicado en 2002

The treatment of advanced colorectal cancer: where are we now and where do we go?

artículo científico publicado en 2002

The treatment of advanced gastric cancer: new findings on the activity of the taxanes.

artículo científico publicado en 2004

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

artículo científico publicado en 2006

Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study

artículo científico publicado en 2017

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

artículo científico publicado en 2010

Tumor response and symptom palliation from RAINBOW, a phase 3 trial of ramucirumab plus paclitaxel in previously treated advanced gastric cancer

artículo científico publicado en 2020

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

artículo científico publicado en 2012

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda